학술논문

Urinary Podocyte mRNA Excretion in Children with D+HUS: A Potential Marker of Long-Term Outcome.
Document Type
Article
Source
Renal Failure. 2006, Vol. 28 Issue 6, p475-482. 8p. 1 Diagram, 2 Graphs.
Subject
*HEMOLYTIC-uremic syndrome
*ACUTE kidney failure
*MESSENGER RNA
*BIOMARKERS
*CHILDREN
Language
ISSN
0886-022X
Abstract
Background . Diarrhea-associated hemolytic uremic syndrome (D+HUS) causes acute renal failure and may lead to podocyte loss. Objective . To determine if the urinary mRNA excretion of podocyte proteins is detectable in children with D+HUS and if it is a biomarker of a poor long-term outcome. Methods . Patients were randomly selected from participants in the SYNSORB Pk® trial. Urine samples were collected daily during the first week of hospitalization. Specimens were also obtained in healthy volunteers. Synaptopodin and nephrin mRNA levels were measured using real-time PCR. Results . Fifteen children, aged 4.9±2.8 years, were studied. Patients were categorized based on urinary mRNA levels into normal (marker:GAPDH≤mean + SD) or high (marker:GAPDH>mean + SD) in controls. Twelve patients (80%) had increased urinary podocyte mRNA excretion; 11 (73%) had high synaptopodin and 5 (33%) had high nephrin mRNA levels. Follow-up data were available in 13/15 patients, all of whom had normal blood pressure, urinalysis, and serum creatinine concentration. Conclusion . The isolation of podocyte mRNA from routine urine samples is feasible in children with D+HUS. Most patients have podocyturia based on synaptopodin and nephrin mRNA excretion. Larger studies with extended follow-up are required to determine the relationship of these biomarkers to long-term renal prognosis in D+HUS. [ABSTRACT FROM AUTHOR]